Paula Moore, MD
Internal Medicine · Vestavia, ALNPI 1952452260
Payments from drug & device makers
Across 46 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$242
- Preventice Services, LLC$211
- Takeda Pharmaceuticals U.S.A., Inc.$198
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$96
- Eisai Inc.$32
- Neurocrine Biosciences, Inc.$31
- plus $97 from 6 others
What the payments were for
- Food & beverage$906100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 14 | $242 |
| Preventice Services, LLC | 3 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $198 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $96 |
| Eisai Inc. | 2 | $32 |
| Neurocrine Biosciences, Inc. | 1 | $31 |
| Bausch Health US, LLC | 2 | $24 |
| Akcea Therapeutics, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| G Medical Diagnostic Services, Inc. | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
| Irhythm Technologies, Inc. | 1 | $12 |
How this compares
$906 in reported general payments places this provider in the 60th percentile of 1,533 internal medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bisoprolol Fumarate | 75 | $5,472 |
| Bupropion XlBupropion Hcl | 102 | $3,727 |
| Clonazepam | 527 | $3,101 |
| Metoprolol Succinate | 95 | $2,967 |
| Duloxetine Hcl | 46 | $2,375 |
| Midodrine Hcl | 22 | $1,511 |
| KlonopinClonazepam | 14 | $1,385 |
| Pyridostigmine Bromide | 16 | $1,010 |
| Escitalopram Oxalate | 58 | $979 |
| Nadolol | 15 | $877 |
| Propranolol Hcl | 48 | $875 |
| Butalbital-AcetaminophenButalbital/Acetaminophen | 12 | $717 |
| Atenolol | 99 | $703 |
| Sodium Chloride0.9 % Sodium Chloride | 33 | $658 |
| Fludrocortisone Acetate | 26 | $650 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Vestavia
- Hayes WilliamsVestavia$10.4M
- Harry StuddardMobile$12.9M
- Almena FreeAnniston$12.7M
- David DeatkineBirmingham$8M
- James SullivanBirmingham$6M
- Ramy TomaBirmingham$5.1M
- Barry McLeanHomewood$4M
- William KirbyBirmingham$2.3M
- Saadat AnsariHuntsville$2.1M
- Gregory FlippoTrussville$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.